Endurant Capital Management LP - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$401,000
-72.5%
16,447
-83.9%
0.16%
-79.4%
Q4 2018$1,458,000
-14.9%
102,345
-9.2%
0.77%
+1.2%
Q3 2018$1,713,000
+25.4%
112,700
+38.4%
0.76%
+28.7%
Q2 2018$1,366,000
+17.3%
81,416
+14.0%
0.59%
+36.1%
Q1 2018$1,165,000
+79.8%
71,400
+41.1%
0.44%
+119.7%
Q4 2017$648,000
-42.1%
50,600
-44.4%
0.20%
-41.6%
Q3 2017$1,119,000
+59.6%
91,000
+8.7%
0.34%
+71.2%
Q2 2017$701,000
+183.8%
83,700
+197.9%
0.20%
+94.1%
Q4 2016$247,000
+263.2%
28,100
+181.0%
0.10%
+308.0%
Q3 2016$68,00010,0000.02%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2018
NameSharesValueWeighting ↓
Redmile Group, LLC 17,850,650$75,330,0005.64%
BVF INC/IL 6,682,711$28,201,0004.81%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,729,361$36,838,0001.49%
First Light Asset Management, LLC 530,391$2,238,0000.94%
KOPP INVESTMENT ADVISORS LLC 376,477$1,589,0000.78%
Sarissa Capital Management LP 700,000$2,954,0000.57%
Orbimed Advisors 10,689,000$45,108,0000.41%
Bedell Frazier Investment Counselling, LLC 178,971$755,0000.37%
PINNACLE ASSOCIATES LTD 3,453,487$14,574,0000.31%
Artal Group S.A. 3,710,000$15,656,0000.29%
View complete list of ARRAY BIOPHARMA INC shareholders